Sponsor or institution

Clinical trials and research at Shanghai Huilun Pharmaceutical Co., Ltd.

• 8Clinical trials
• 1Country

Newest trials

All recruiting trials (8)

• HL-1186 Tablet for postherpetic neuralgia: safety and efficacy in adults

  This study tests whether HL-1186 tablets, compared with placebo and with pregabalin, help reduce pain in adults with postherpetic neuralgia.

  Recruiting Phase 2 Shanghai Huilun Pharmaceutical Co., Ltd. · Beijing · NCT07758920

• HL-1186 Tablet for postoperative pain after abdominal surgery

  This trial tests HL-1186 tablets to see if they reduce pain after abdominal surgery compared with placebo and an oxycodone-acetaminophen option.

  Recruiting Phase 2/3 Shanghai Huilun Pharmaceutical Co., Ltd. · Chengdu, Sichuan · NCT07709598

• HL-1186 Tablet for postoperative pain after orthopedic surgery

  A mid-to-late phase trial tests HL-1186 tablets against placebo and standard opioid therapy to see if they can help manage pain after orthopedic surgery for adults 18–75.

  Recruiting Phase 2/3 Shanghai Huilun Pharmaceutical Co., Ltd. · Changsha, Hunan · NCT07699601

• YD0743 for sepsis-associated ARDS in adults

  This trial will test whether YD0743 can shorten the number of days adults in the ICU with sepsis-associated ARDS need a ventilator and whether the drug is safe to use.

  Recruiting Phase 2 Shanghai Huilun Pharmaceutical Co., Ltd. · Beijing · NCT07413094

• HL-1186 tablets for reducing pain after abdominal surgery

  This trial will test whether HL-1186 tablets reduce moderate to severe pain after abdominal surgery in adults aged 18–75.

  Recruiting Phase 2 Shanghai Huilun Pharmaceutical Co., Ltd. · Changsha, Hunan · NCT07311369

• HTMC0658 tablets to treat chronic sinusitis without nasal polyps

  This trial will test whether HTMC0658 tablets can help adults with chronic rhinosinusitis without nasal polyps feel better and have fewer sinus symptoms.

  Recruiting Phase 2 Shanghai Huilun Pharmaceutical Co., Ltd. · Luoyang, Henan · NCT07174115

• HL-1186 tablets to treat moderate to severe pain after surgery.

  This Phase 2 test will try HL-1186 tablets to see if they reduce moderate to severe postoperative pain in adults having elective orthopedic, abdominal, or thoracic surgery.

  Recruiting Phase 2 Shanghai Huilun Pharmaceutical Co., Ltd. · Chengdu, Sichuan · NCT07147049

• Assessing the safety and tolerability of HL-1186 in healthy individuals

  This study is testing a new oral tablet called HL-1186 in healthy people to see if it is safe and how well it is tolerated compared to a placebo.

  Recruiting Phase 1 Shanghai Huilun Pharmaceutical Co., Ltd. · Wuxi · NCT06912295

Quick answers

How many clinical trials run by Shanghai Huilun Pharmaceutical Co., Ltd. are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 2/3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →